Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VINORELBINE INJECTION, USP - Health Canada Drug Approval Details

Approvals/Health Canada/VINORELBINE INJECTION, USP

Authorized

STANDARD

VINORELBINE INJECTION, USP

FRESENIUS KABI CANADA LTD🇨🇦 Health Canada

Approval Date: Apr 6, 2026
Approval ID: 0e3fa5a16d19bd89
Company: FRESENIUS KABI CANADA LTD
Type: Standard

Approval Details

Approval Id: 0e3fa5a16d19bd89
Drug Approval Canada Name: VINORELBINE INJECTION, USP
Product Name: VINORELBINE INJECTION, USP
Status: Marketed
Status Date: 2021-06-25
Original Market Date: 2021-06-25
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: PRESCRIPTION
Ahfs: 10:00.00
Atc Original: L01CA04 VINORELBINE
Aig Number: 0126071001
Company Name: FRESENIUS KABI CANADA LTD
Company Address: 165 Galaxy Blvd, Suite 100 Toronto Ontario Canada M9W 0C8

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

0e3fa5a16d19bd89

Type

Standard

Back to Health Canada Approvals